GlassScriptPhysician profile
Rhonda M Guy
NPI 1457356545
$1,677.75
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $961 · 2021: $13.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $451.93 | 2019-2020 | |
| Lilly USA, LLC | $223.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.40 | 2019-2020 | |
| Novo Nordisk INC | $190.56 | 2019-2020 | |
| Astellas Pharma US INC | $174.96 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.78 | 2019-2021 | |
| Pfizer INC. | $54.39 | 2019-2020 | |
| Allergan, INC. | $41.67 | 2020 | |
| Amgen INC. | $29.71 | 2019 | |
| Glaxosmithkline, LLC. | $21.15 | 2020 | |
| Scilex Pharmaceuticals INC. | $20.33 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.17 | 2019 | |
| Abbvie INC. | $16.92 | 2020 | |
| Amarin Pharma, INC. | $16.52 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $14.26 | 2020 | |
| Redhill Biopharma INC. | $13.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.33 | 2019 | |
| Esperion Therapeutics, INC. | $12.31 | 2020 | |
| Shire North American Group INC | $12.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhonda Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.